Rempex Pharmaceuticals Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $140M

Rempex Pharmaceuticals General Information

Description

Developer of new antibacterial drugs to meet the growing clinical need created by multi-drug resistant bacterial pathogens. The company's internal development pipeline focuses on combining proprietary formulation and potentiating agents with antibiotics to overcome or directly inhibit the molecular mechanisms in bacteria responsible for antibiotic resistance.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 11535 Sorrento Valley Road
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 11535 Sorrento Valley Road
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rempex Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 04-Dec-2013 $140M Completed Clinical Trials - Phase 1
2. Early Stage VC (Series B) 22-Jan-2013 Completed Clinical Trials - Phase 1
1. Early Stage VC (Series A) 10-Jun-2011 $8.5M $8.5M Completed Product Development
To view Rempex Pharmaceuticals’s complete valuation and funding history, request access »

Rempex Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Rempex Pharmaceuticals’s complete cap table history, request access »

Rempex Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of new antibacterial drugs to meet the growing clinical need created by multi-drug resistant bacterial pathoge
Drug Discovery
San Diego, CA

Wilmington, DE
 

Edmonton, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Rempex Pharmaceuticals Competitors (21)

One of Rempex Pharmaceuticals’s 21 competitors is Bugworks Research, a Private Equity-Backed company based in Wilmington, DE.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bugworks Research Private Equity-Backed Wilmington, DE
Fedora Pharmaceuticals Venture Capital-Backed Edmonton, Canada
Eligo Bioscience Venture Capital-Backed Paris, France
Ability Pharma Private Equity-Backed Cerdanyola, Spain
NovaBiotics Venture Capital-Backed Aberdeen, United Kingdom
You’re viewing 5 of 21 competitors. Get the full list »

Rempex Pharmaceuticals Patents

Rempex Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019212883-A1 Methods of treating bacterial infections with minocycline Inactive 30-Apr-2018
US-11999757-B2 Synthesis of boronate ester derivatives and uses thereof Active 01-Nov-2017
US-20190127396-A1 Synthesis of boronate ester derivatives and uses thereof Inactive 01-Nov-2017
US-20200308197-A1 Synthesis of boronate ester derivatives and uses thereof Active 01-Nov-2017
WO-2019089542-A1 Synthesis of boronate ester derivatives and uses thereof Inactive 01-Nov-2017 C07C69/675
To view Rempex Pharmaceuticals’s complete patent history, request access »

Rempex Pharmaceuticals Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adams Street Partners PE/Buyout Minority
Frazier Healthcare Partners PE/Buyout Minority
OrbiMed Growth/Expansion Minority
SV Health Investors PE/Buyout Minority
Vivo Capital Venture Capital Minority
To view Rempex Pharmaceuticals’s complete investors history, request access »

Rempex Pharmaceuticals FAQs

  • When was Rempex Pharmaceuticals founded?

    Rempex Pharmaceuticals was founded in 2011.

  • Where is Rempex Pharmaceuticals headquartered?

    Rempex Pharmaceuticals is headquartered in San Diego, CA.

  • What industry is Rempex Pharmaceuticals in?

    Rempex Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Rempex Pharmaceuticals a private or public company?

    Rempex Pharmaceuticals is a Private company.

  • What is the current valuation of Rempex Pharmaceuticals?

    The current valuation of Rempex Pharmaceuticals is .

  • What is Rempex Pharmaceuticals’s current revenue?

    The current revenue for Rempex Pharmaceuticals is .

  • How much funding has Rempex Pharmaceuticals raised over time?

    Rempex Pharmaceuticals has raised $76M.

  • Who are Rempex Pharmaceuticals’s investors?

    Adams Street Partners, Frazier Healthcare Partners, OrbiMed, SV Health Investors, and Vivo Capital have invested in Rempex Pharmaceuticals.

  • Who are Rempex Pharmaceuticals’s competitors?

    Bugworks Research, Fedora Pharmaceuticals, Eligo Bioscience, Ability Pharma, and NovaBiotics are some of the 21 competitors of Rempex Pharmaceuticals.

  • When was Rempex Pharmaceuticals acquired?

    Rempex Pharmaceuticals was acquired on 04-Dec-2013.

  • Who acquired Rempex Pharmaceuticals?

    Rempex Pharmaceuticals was acquired by The Medicines Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process